Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QuantRx, Fieldtests in DOA test manufacturing and distribution pact:

This article was originally published in Clinica

Executive Summary

Drugs-of-abuse (DOA) testing specialists QuantRx Biomedical and Fieldtests have entered a manufacturing and distribution agreement that will see QuantRx exclusively manufacture the Fieldtests ID product line. According to Doylestown, Pennsylvania-based QuantRx, the product line, which is designed to test for narcotic residue, will be available during the second quarter of 2008. The agreement will also see Fieldtests distribute QuantRx's QuikSense DOA products through its sales network. Fieldtests intends to extend the deal to cover QuantRx's RapidSense lateral flow test and OralSense oral fluid collection device when these products become commercially available. Financial details of the deal were not revealed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel